Skin Tag and Acanthosis Nigricans: Do they have a Predictive Value for Gestational Diabetes Mellitus?

Abstract

Background: Gestational diabetes mellitus (GDM) is a metabolic condition that can cause severe fetal and maternal morbidity. Early diagnosis and treatment of GDM can significantly prevent maternal and perinatal morbidity.

Objective: To investigate and compare the prevalence of gestational diabetes mellitus in pregnant women with skin tag (ST) and/or acanthosis nigricans (AN) and a control group.

Methods: This cross-sectional study was conducted at Adana Numune Educational and Research Hospital, Seyhan Practice Center, Dermatology and Obstetrics Clinics between March, 2006 and July, 2008. All 249 pregnant women without risk factors for GDM examined dermatologically in terms of AN and ST in the first antenatal visit. A 50 g glucose screening test and, if test positive, 100 g oral glucose tolerance test was performed between theirs 24 and 28 weeks of pregnancy. GDM was diagnosed according to American Diabetes Association (ADA) criteria. AN and ST prevalence were compared in women with GDM and without GDM.

Results: 35.8% of the pregnant women with AN had GDM, while the same ratio was 9.2% for the women without AN. The probability of pregnant women with AN having GDM is 5.5 (95%CI: 2.6–11.6) times more than the pregnant women without AN. Among the pregnant women with both ST and AN, 40.0% of them had GDM, while the same ratio was 12.3% for the women free of both ST and AN. In this instance, the difference between the ratios was found statistically significant (p=0.001). Based on the results, the probability of pregnant women with both ST and AN having GDM is 4.8 (95%CI: 1.9–11.7) times more than the pregnant women without ST and AN.

Conclusions: AN or AN with ST may be a risk factor for GDM. If this supported with large case-control study, early screening for GDM to prevent serious complications of disease should be done in pregnant women with AN.

acanthosis nigricans - diagnosis - gestational diabetes mellitus - screening - skin tag

References

• 1 Banik R, Lubach D. Skin tags: localization and frequencies according to sex and age.  Dermatologica. 1987;  174 180-183
• 2 Bhargava P, Mathur D. Acrochordon, diabetes and associations.  Indian J Dermatol Venereol Leprol. 1996;  62 226-228
• 3 Kong AS, Williams RL, Smith M. et al . Acanthosis nigricans and diabetes risk factors: prevalence in young person's seen in southwestern US primary care practices.  Ann Fam Med. 2007;  5 202-208
• 4 Hermanns-Le T, Scheen A, Pierard GE. Acanthosis nigricans associated with insulin resistance: pathophysiology and management.  Am J Clin Dermatol. 2004;  5 199-203
• 5 Damm P, Kuhl C, Bertelsen A. et al . Predictive factors for the development of diabetes in women with previous gestational diabetes mellitus.  Am J Obstet Gynecol. 1992;  167 607-616
• 6 American Diabetes Association . Diagnosis and classification of Diabetes Mellitus.  Diabetes Care. 2004;  27 (Suppl. 1) 5-14
• 7 American Diabetes Association . Position statement: Gestational diabetes.  Diabetes Care. 1993;  16 (Suppl. 2) 5
• 8 Lopez-alvarenga JC, Garcia-Hidalgo L, Landa-Anell MV. et al . Influence of skin color on the diagnostic utility of clinical acanthosis nigricans to predict insulin resistance in obese patients.  Arch Med Res. 2006;  37 744-748
• 9 Rasi A, Soltani-Arabshahi R, Shahbazi N. Skin tag as a cutaneous marker for impaired carbohydrate metabolism: a case-control study.  Int J Dermatol. 2007;  46 1155-1159
• 10 Odent M. Gestational diabetes and health promotion.  Lancet. 2009;  374 684
• 11 Touraine A. A new hereditary chain; cutaneous fibromas, diabetes, obesity.  Ann Dermatol Syphiligr. 1951;  78 409-416
• 12 Kahana M, Grossman E, Feinstein A. et al . Skin tags: a cutaneous marker for diabetes mellitus.  Acta Derm Venereol. 1987;  67 175-177
• 13 Mathur SK, Bhargava P. Insulin resistance and skin tags.  Dermatology. 1997;  195 184
• 14 Sudy E, Urbina F, Maligueo M. et al . Screening of glucose/insulin metabolic alterations in men with multiple skin tags on the neck.  J Dtsch Dematol Ges. 2008;  10 112-116
• 15 Varthakavi PK, Waingankar A, Patel KL. et al . Acanthosis nigricans: A dermatologic marker of metabolic disease.  Indian J Dermatol Venereol Leprol. 2002;  68 67-72
• 16 Rogers DL. Acanthosis nigricans.  Seminar Dermatol. 1991;  10 160-161
• 17 Dunaif A, Green G, Phelps RG. et al . Acanthosis nigricans, Insulin action and hyperandrogenism: Clinical, histological and biochemical findings.  J Clin Endo Metab. 1991;  73 590-595
• 18 Gemer O, Segal S, Segal O. et al . Acanthosis nigricans and hyperandrogenism in a pregnancy complicated by diabetes.  Obstet Gynecol. 1993;  81 810-811
• 19 Brickman WJ, Binns HJ, Jovanovic BD. et al . Acanthosis nigricans: a common finding in overweigth youth.  Pediatr Dermatol. 2007;  24 601-606
• 20 Cordain L, Eades MR, Eades MD. Hyperinsulinemic diseases of civilization: more than just syndrome X.  Comp Biochem Physiol A Mol Integr Physiol. 2003;  136 95-112

Correspondence